Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 7-8, 2011, Pages 962-972

  Stibbe, Krista J M ^a   Verveer, Claudia ^a   Francke, Jan ^a   Hansen, Bettina E ^a   Zondervan, Pieter E ^a   Kuipers, Ernst J ^a   De Knegt, Robert J ^a   Van Vuuren, Anneke J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breath tests; Fibrosis; Non invasive diagnostics; Serum markers; Transient elastography

Indexed keywords

4 ACETANISIDINE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GALACTOSE; HYALURONIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE PLATELET RATIO INDEX; BREATHING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ELASTOGRAPHY; FEMALE; FIB 4 TEST; FIBROTEST; GALACTOSE BREATH TEST; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METHACETIN BREATH TEST; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; THROMBOCYTE VOLUME;

ACETAMIDES; ADULT; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD PLATELETS; BREATH TESTS; ELASTICITY IMAGING TECHNIQUES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GALACTOSE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; LINEAR MODELS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ROC CURVE;

EID: 79960258812     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.574725     Document Type: Article

References (41)

1. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
2. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
3. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93. (Pubitemid 26260021)
4. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-74. (Pubitemid 38917824)
5. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999;30: 1529-30.
6. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128: 343-50. (Pubitemid 40439195)
7. Braden B, Faust D, Sarrazin U, Zeuzem S, Dietrich CF, Caspary WF, et al. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2005;21:179-85. (Pubitemid 40222971)
8. Esmat G, Metwally M, Zalata KR, Gadalla S, Abdel- Hamid M, Abouzied A, et al. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J Hepatol 2007;46:620-7. (Pubitemid 46402951)
9. Saadeh S, Behrens PW, Parsi MA, Carey WD, Connor JT, Grealis M, et al. The utility of the 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther 2003; 18:995-1002. (Pubitemid 37475959)
10. Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scand J Gastroenterol 2006;41:1336-41. (Pubitemid 44639307)
11. Festi D, Capodicasa S, Sandri L, Colaiocco-Ferrante L, Staniscia T, Vitacolonna E, et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels. World J Gastroenterol 2005;11:142-8. (Pubitemid 40090153)
12. Yilmaz S, Bayan K, Tuzun Y, Dursun M, Kaplan A, Ozmen S, et al. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Int J Clin Pract 2007;61:438-43.
13. M. Philips VRPaRDH. Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? Eur J Gastroenterol Hepatol 2003;15(9):941-4.
14. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38: 518-26. (Pubitemid 36919874)
15. Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008;40:267-74. (Pubitemid 351292341)
16. Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, et al. Stepwise combination algorithms of noninvasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:686-93.
17. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007;7:40.
18. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-6. (Pubitemid 47171918)
19. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-25. (Pubitemid 43980111)
20. Arends JE, de Knegt RJ, van Erpecum KJ, Hoepelman IM. Diagnosis of hepatic fibrosis and cirrhosis. Ned Tijdschr Geneeskd 2007;151:1502-6. (Pubitemid 47111011)
21. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006;43:S113-20.
22. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13. (Pubitemid 38091720)
23. Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol 2006;18:1321-5. (Pubitemid 44737064)
24. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960-74.
25. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8.
26. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55: 403-8. (Pubitemid 43268281)
27. Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006;12:4325-30. (Pubitemid 44194524)
28. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57. (Pubitemid 37466971)
29. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011;53:325-35.
30. Kasicka-Jonderko A, Jonderko K, Chabior E, Blonska- Fajfrowska B. Exact profiles of (13)CO(2) recovery in breath air after per oral administration of (13)C.methacetin in two groups of different ages. Isotopes Environ Health Stud 2008; 44:295-303.
31. Lalazar G, Pappo O, Hershcovici T, Hadjaj T, Shubi M, Ohana H, et al. A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat 2008;15:716-28.
32. Mion F, Rousseau M, Scoazec JY, Berger F, Minaire Y. 13C.-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C. Eur J Clin Invest 1999;29:624-9. (Pubitemid 29322375)
33. Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, Botta-Fridlund D, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol 2005;4:6.
34. Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, et al. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 2005;5:32.
35. Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, Giry C, et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409-15.
36. Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 2010;10:103.
37. Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, et al. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 2010;59:1401-9.
38. Friedrich-Rust M, Wunder K, Kriener S, Sotoudeh F, Richter S, Bojunga J, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009;252: 595-604.
39. Poynard T, Ngo Y, Munteanu M, Thabut D, Massard J, Moussalli J, et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Antivir Ther 2010;15:617-31.
40. Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, et al. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1821-7.
41. Cobbold JF, Crossey MM, Colman P, Goldin RD, Murphy PS, Patel N, et al. Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C. J Viral Hepat 2010;17:537-45.